Search

We observed ten children with a papular eruption with purpuric features during the SARS‐CoV‐2 pandemic in Northern Italy (May‐December 2020). Histological examination showed signs of SARS‐CoV‐2‐related dermatosis. Evidence of nucleocapsid viral proteins using SARS‐CoV‐2 (2019‐nCoV) nucleocapsid antibody revealed cuticular staining of the deep portion of the eccrine glands in all cases. [ABSTRACT FROM AUTHOR]

Psoriasis onset under dupilumab treatment in two patients affected by atopic dermatitis and one patient affected by alopecia areata: clinical and dermoscopic patterns. Dear Editor, Dupilumab was approved by European Medicine Agency (EMA) in 2020 for use in children aged 6-11 years with severe atopic dermatitis (AD). When initiating therapy with dupilumab the patient presented an Eczema Area and Severity Index (EASI) of 30, an Itch Numeric Rating Scale (NRS) of six and a Dermatology Life Quality Index (DLQI) of six. [Extracted from the article]

It has been reported that the novel coronavirus disease (COVID‐19) may be associated with a papulovesicular skin eruption predominantly involving the trunk. We hereby present a case of COVID‐19–associated varicella‐like exanthem in an 8‐year‐old girl with mild systemic symptoms. [ABSTRACT FROM AUTHOR]